Skip to main content

Open Access Impurity profile study of dutasteride

Download Article:
(PDF 119.6142578125 kb)


During the process development of dutasteride in the laboratory analysis showed some impurity peaks in HPLC ranging from 0.05 to 0.1%. The same samples were analyzed by LCMS method and identified peak at m/z 508 (desmethyl dutasteride), 530 (dihydro dutasteride) and 528 (isomer of dutasteride). These impurities were synthesized individually and characterized based on the spectroscopic data (HPLC, IR, NMR and MS). The structures of these impurities were 17β-N-[2,5-bis(trifluoromethyl) phenyl]carbamoyl-3-hydroxyl-4-azaestra-1,3,5,7,9-pentaene (desmethyl of dutasteride 2), 17β-N-[2,5-bis(trifluoromethyl)phenyl]carbamoyl-4-aza-5α-androstane-3-one (dihydro impurity of dutasteride 3), and 17β-N-[2,5-bis(trifluoromethyl) phenyl] carbamoyl-4-aza-5β-androst-1-ene-3-one (β-isomer of dutasteride 4), respectively. The formation and synthesis of dutasteride impurities are discussed.

Document Type: Research Article


Affiliations: 1: Dr. Reddy's Laboratories Ltd, Jinnaram, Andhra Pradesh, India 2: Institute of Science and Technology, Center for Environmental Science, J.N.T. University, Kukatpally, Hyderabad, Andhra Pradesh, India 3: Dr. Reddy's Laboratories Ltd, Unit-III, Plot No.116, S.V.Co-Op. Industrial Estate, Bollaram, Strasse, Jinnaram, Medak, Andhra Pradesh, Dist-502 325, India

Publication date: 2007-10-01

More about this publication?
  • Pharmazie is a leading journal in the field of pharmaceutical sciences. As a peer-reviewed scientific journal, Pharmazie is regularly indexed in the relevant databases like Web of science, Journal Citation Reports and many others. The journal is open for submissions from the whole spectrum of pharnaceutical sciences including Pharmaceutical Chemistry, Experimental and Clinical Pharmacology, Drug Analysis, Pharmaceutics, Pharmaceutical Biology, Clinical Pharmacy etc.
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more